Inventiva (IVA) Non-Current Deffered Revenue (2018 - 2025)

Inventiva's (IVA) quarterly Non-Current Deffered Revenue came in at $146669.5 in Q4 2025, up 28.28% year-on-year from $114339.7 in Q4 2024, and down 99.9% quarter-over-quarter from $142.6 million in Q2 2025.

Inventiva (IVA) Non-Current Deffered Revenue (2018 - 2025) Analysis & Trends

Inventiva's Non-Current Deffered Revenue history runs 5 years deep, the most recent figure standing at $146669.5 for Q4 2025.

  • On a quarterly basis, Non-Current Deffered Revenue rose 28.28% year-over-year to $146669.5 in Q4 2025; TTM through Dec 2025 was $146669.5, a 28.28% increase from a year earlier, with the FY2025 full-year figure at $146669.5, up 28.28% from the prior year.
  • Non-Current Deffered Revenue eased to $146669.5 in Q4 2025 per IVA's latest filing, from $142.6 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $142.6 million in Q2 2025 and bottomed at $56113.6 in Q4 2022.
  • The 4-year median for Non-Current Deffered Revenue is $94827.8 (2023), against an average of $23.8 million.
  • Across the five-year window, Non-Current Deffered Revenue jumped 51.81% in 2024 and climbed 28.28% in 2025, its largest moves.
  • Year by year, Non-Current Deffered Revenue stood at $56113.6 in 2022, then jumped by 34.22% to $75315.8 in 2023, then surged by 51.81% to $114339.7 in 2024, then gained by 28.28% to $146669.5 in 2025.
  • Per Business Quant, the three latest IVA Non-Current Deffered Revenue figures stand at $146669.5 (Q4 2025), $142.6 million (Q2 2025), and $114339.7 (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 225.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Inventiva 842.48 Mn 842.48 Mn - 146,669.48

Historic Data

Download Data
DateValue
Dec 31, 2025 146,669.48
Jun 30, 2025 142.63 Mn
Dec 31, 2024 114,339.71
Dec 31, 2023 75,315.79
Jun 30, 2023 66,424.39
Dec 31, 2022 56,113.61
Dec 31, 2018 1.91 Mn